Clinical applications of interleukin-2
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Progress in Growth Factor Research
- Vol. 4 (3) , 229-246
- https://doi.org/10.1016/0955-2235(92)90021-9
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinomaEuropean Journal Of Cancer, 1992
- Phase II Study of Intravenous Bolus Recombinant Interleukin-2 in Advanced Malignant Melanoma: Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1991
- Interleukin-2 Lymphokine-Activated Killer Cell Therapy of Non-Hodgkinʼs Lymphoma and Hodgkinʼs DiseaseJournal of Immunotherapy, 1991
- High-Dose Recombinant Interleukin-2 Alone: A Regimen With Limited Activity in the Treatment of Advanced Renal Cell CarcinomaJNCI Journal of the National Cancer Institute, 1990
- Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Interleukin-2 in Combination with Interferon-Alpha in Disseminated Malignant Melanoma and Advanced Renal Cell CarcinomaOncology Research and Treatment, 1990
- Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignanciesCancer Treatment Reviews, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Combination Immunotherapy for Cancer:Synergistic Antitumor Interactions of Interleukin-2, Alfa Interferon, and Tumor-Infiltrating LymphocytesJNCI Journal of the National Cancer Institute, 1988
- Biotherapy: The fourth modality of cancer treatmentJournal of Cellular Physiology, 1986